Evidence map›Paper›PMID 33573397›Full record

ArticleBone & joint open2021

Elective orthopaedic cancellations due to the COVID-19 pandemic: where are we now, and where are we heading?

Sam Oussedik, Sam MacIntyre, Joanne Gray, Peter McMeekin, Nick D Clement, David J Deehan

Abstract read
In one paragraph

Article in Bone & joint open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The outcomes of total hip arthroplasty in rapidly progressive osteoarthritis: a systematic review.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2023
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Factors associated with a clinically significant improvement in health-related quality of life after total knee arthroplasty.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sam OussedikDepartment of Orthopaedics, University College London Hospitals, London, UK.
Sam MacIntyreBarcelona Graduate School of Economics, Barcelona, Spain.
Joanne GrayDepartment of Nursing, Midwifery and Health, Northumbria University, Northumbria, UK.
Peter McMeekinDepartment of Nursing, Midwifery and Health, Northumbria University, Northumbria, UK.ORCID https://orcid.org/0000-0003-0946-7224
Nick D ClementDepartment of Orthopaedics, Royal Infirmary of Edinburgh, Edinburgh, UK.
David J DeehanDepartment of Orthopaedics, Freeman Hospital, Newcastle, UK.

Funding

Medical Research Council MR/K02325X/1
6 · The paper itself

Abstract

aimsThe primary aim is to estimate the current and potential number of patients on NHS England orthopaedic elective waiting lists by November 2020. The secondary aims are to model recovery strategies; review the deficit of hip and knee arthroplasty from National Joint Registry (NJR) data; and assess the cost of returning to pre-COVID-19 waiting list numbers.

methodsA model of referral, waiting list, and eventual surgery was created and calibrated using historical data from NHS England (April 2017 to March 2020) and was used to investigate the possible consequences of unmet demand resulting from fewer patients entering the treatment pathway and recovery strategies. NJR data were used to estimate the deficit of hip and knee arthroplasty by August 2020 and NHS tariff costs were used to calculate the financial burden.

resultsBy November 2020, the elective waiting list in England is predicted to be between 885,286 and 1,028,733. If reduced hospital capacity is factored into the model, returning to full capacity by November, the waiting list could be as large as 1.4 million. With a 30% increase in productivity, it would take 20 months if there was no hidden burden of unreferred patients, and 48 months if there was a hidden burden, to return to pre-COVID-19 waiting list numbers. By August 2020, the estimated deficits of hip and knee arthroplasties from NJR data were 18,298 (44.8%) and 16,567 (38.6%), respectively, compared to the same time period in 2019. The cost to clear this black log would be £198,811,335.

conclusionThere will be up to 1.4 million patients on elective orthopaedic waiting lists in England by November 2020, approximate three-times the pre-COVID-19 average. There are various strategies for recovery to return to pre-COVID-19 waiting list numbers reliant on increasing capacity, but these have substantial cost implications. Cite this article:

Indexed as

arthroplastyCOVID-19economicshealth policy

Identifiers

PMID33573397
PMCPMC7925214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.